 | • レポートコード：QYR2104Z4764 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、着床前遺伝子診断（PGD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（染色体異常、X連鎖性疾患、凍結胚検査、異数性スクリーニング、HLA、その他）、用途別市場規模（幹細胞治療、IVF予後、遅発性遺伝性疾患、遺伝性遺伝性疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・着床前遺伝子診断（PGD）の市場動向 ・企業の競争状況、市場シェア ・着床前遺伝子診断（PGD）の種類別市場規模（染色体異常、X連鎖性疾患、凍結胚検査、異数性スクリーニング、HLA、その他） ・着床前遺伝子診断（PGD）の用途別市場規模（幹細胞治療、IVF予後、遅発性遺伝性疾患、遺伝性遺伝性疾患、その他） ・着床前遺伝子診断（PGD）の北米市場規模2016-2027（アメリカ、カナダ） ・着床前遺伝子診断（PGD）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・着床前遺伝子診断（PGD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・着床前遺伝子診断（PGD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・着床前遺伝子診断（PGD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Genea Limited、Quest Diagnostics、Illumina, Inc.、Natera, Inc.、Cooper Medical, Inc.、LabCorp、California Pacific Medical Center (CPMC)、Thermo Fisher Scientific Inc.、IGENOMIX、Reproductive Genetic Innovations、CombiMatrix） ・結論 |
Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.
When used to screen for a specific genetic disease, PGD main advantage is that it avoids selective abortion, as the method makes it highly likely that the baby will be free of the disease under consideration. PGD thus is an adjunct to assisted reproductive technology, and requires in vitro fertilization (IVF) to obtain oocytes or embryos for evaluation. Embryos are generally obtained through blastomere or blastocyst biopsy.
Market Analysis and Insights: Global Pre-Implantation Genetic Diagnosis (PGD) Market
The global Pre-Implantation Genetic Diagnosis (PGD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pre-Implantation Genetic Diagnosis (PGD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pre-Implantation Genetic Diagnosis (PGD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pre-Implantation Genetic Diagnosis (PGD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pre-Implantation Genetic Diagnosis (PGD) market.
Global Pre-Implantation Genetic Diagnosis (PGD) Scope and Market Size
Pre-Implantation Genetic Diagnosis (PGD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pre-Implantation Genetic Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chromosomal Abnormalities
X-linked Diseases
Freeze Embryo Testing
Aneuploidy Screening
HLA
Others
Segment by Application
Stem Cell Therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chromosomal Abnormalities
1.2.3 X-linked Diseases
1.2.4 Freeze Embryo Testing
1.2.5 Aneuploidy Screening
1.2.6 HLA
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stem Cell Therapy
1.3.3 IVF Prognosis
1.3.4 Late-Onset Genetic Disorders
1.3.5 Inherited Genetic Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2016-2027)
2.2 Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Regions
2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2016-2021)
2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027)
2.3 Pre-Implantation Genetic Diagnosis (PGD) Industry Dynamic
2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Market Trends
2.3.2 Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
2.3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
2.3.4 Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2016-2021)
3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2016-2021)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2020
3.5 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Type
4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2016-2021)
4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027)
5 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Application
5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Application (2016-2021)
5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
6.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
6.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
6.2.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
6.2.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
6.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
6.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
6.3.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
6.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
6.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
7.2.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
7.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
7.2.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
7.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
7.3.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
7.3.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
7.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
7.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
8.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
8.2.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
8.3.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.4.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
9.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
9.2.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
9.2.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
9.2.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
9.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
9.3.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
9.3.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
9.3.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
9.4 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
9.4.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
9.4.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
10.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
10.2.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
10.3.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
10.4.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Genea Limited
11.2.1 Genea Limited Company Details
11.2.2 Genea Limited Business Overview
11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.2.5 Genea Limited Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.3.5 Quest Diagnostics Recent Development
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.4.5 Illumina, Inc. Recent Development
11.5 Natera, Inc.
11.5.1 Natera, Inc. Company Details
11.5.2 Natera, Inc. Business Overview
11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.5.5 Natera, Inc. Recent Development
11.6 Cooper Medical, Inc.
11.6.1 Cooper Medical, Inc. Company Details
11.6.2 Cooper Medical, Inc. Business Overview
11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.6.5 Cooper Medical, Inc. Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.7.5 LabCorp Recent Development
11.8 California Pacific Medical Center (CPMC)
11.8.1 California Pacific Medical Center (CPMC) Company Details
11.8.2 California Pacific Medical Center (CPMC) Business Overview
11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.8.5 California Pacific Medical Center (CPMC) Recent Development
11.9 Thermo Fisher Scientific Inc.
11.9.1 Thermo Fisher Scientific Inc. Company Details
11.9.2 Thermo Fisher Scientific Inc. Business Overview
11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.9.5 Thermo Fisher Scientific Inc. Recent Development
11.10 IGENOMIX
11.10.1 IGENOMIX Company Details
11.10.2 IGENOMIX Business Overview
11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.10.5 IGENOMIX Recent Development
11.11 Reproductive Genetic Innovations
11.11.1 Reproductive Genetic Innovations Company Details
11.11.2 Reproductive Genetic Innovations Business Overview
11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.11.5 Reproductive Genetic Innovations Recent Development
11.12 CombiMatrix
11.12.1 CombiMatrix Company Details
11.12.2 CombiMatrix Business Overview
11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.12.5 CombiMatrix Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chromosomal Abnormalities
Table 3. Key Players of X-linked Diseases
Table 4. Key Players of Freeze Embryo Testing
Table 5. Key Players of Aneuploidy Screening
Table 6. Key Players of HLA
Table 7. Key Players of Others
Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2016-2021)
Table 12. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
Table 14. Pre-Implantation Genetic Diagnosis (PGD) Market Trends
Table 15. Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
Table 16. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
Table 17. Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players (2016-2021)
Table 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2020)
Table 21. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
Table 25. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2016-2021)
Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Pre-Implantation Genetic Diagnosis (PGD) Product
Table 68. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Genea Limited Company Details
Table 71. Genea Limited Business Overview
Table 72. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product
Table 73. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 74. Genea Limited Recent Development
Table 75. Quest Diagnostics Company Details
Table 76. Quest Diagnostics Business Overview
Table 77. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product
Table 78. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 79. Quest Diagnostics Recent Development
Table 80. Illumina, Inc. Company Details
Table 81. Illumina, Inc. Business Overview
Table 82. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 83. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 84. Illumina, Inc. Recent Development
Table 85. Natera, Inc. Company Details
Table 86. Natera, Inc. Business Overview
Table 87. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 88. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 89. Natera, Inc. Recent Development
Table 90. Cooper Medical, Inc. Company Details
Table 91. Cooper Medical, Inc. Business Overview
Table 92. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 93. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 94. Cooper Medical, Inc. Recent Development
Table 95. LabCorp Company Details
Table 96. LabCorp Business Overview
Table 97. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product
Table 98. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 99. LabCorp Recent Development
Table 100. California Pacific Medical Center (CPMC) Company Details
Table 101. California Pacific Medical Center (CPMC) Business Overview
Table 102. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 103. California Pacific Medical Center (CPMC) Recent Development
Table 104. Thermo Fisher Scientific Inc. Company Details
Table 105. Thermo Fisher Scientific Inc. Business Overview
Table 106. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 107. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 108. Thermo Fisher Scientific Inc. Recent Development
Table 109. IGENOMIX Company Details
Table 110. IGENOMIX Business Overview
Table 111. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product
Table 112. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 113. IGENOMIX Recent Development
Table 114. Reproductive Genetic Innovations Company Details
Table 115. Reproductive Genetic Innovations Business Overview
Table 116. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product
Table 117. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 118. Reproductive Genetic Innovations Recent Development
Table 119. CombiMatrix Company Details
Table 120. CombiMatrix Business Overview
Table 121. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product
Table 122. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 123. CombiMatrix Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2020 VS 2027
Figure 2. Chromosomal Abnormalities Features
Figure 3. X-linked Diseases Features
Figure 4. Freeze Embryo Testing Features
Figure 5. Aneuploidy Screening Features
Figure 6. HLA Features
Figure 7. Others Features
Figure 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2027
Figure 9. Stem Cell Therapy Case Studies
Figure 10. IVF Prognosis Case Studies
Figure 11. Late-Onset Genetic Disorders Case Studies
Figure 12. Inherited Genetic Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions: 2020 VS 2027
Figure 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2020
Figure 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2020
Figure 22. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Figure 23. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027)
Figure 24. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 26. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 27. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 28. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 32. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 33. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 34. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2016-2027)
Figure 44. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 52. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 54. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 60. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 64. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 65. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 66. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 67. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 68. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 69. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 70. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 71. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 72. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 73. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 74. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の着床前遺伝子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preimplantation Genetic Diagnosis Market The global Preimplantation Genetic Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…- 世界の着床前遺伝子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preimplantation Genetic Diagnosis Market The global Preimplantation Genetic Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界の遺伝子検査市場規模・現状・予測（2021年-2027年） Genetic testing, also known as DNA testing, allows the determination of bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. In agriculture, a form of genetic testing known as progeny testing can be used to evaluate the quality of breeding stock. In population ecology, gene…
- 世界の出生前遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の消費者直接（DTC）型遺伝子検査市場規模・現状・予測（2021年-2027年） Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the…